Original Research
Optometry & Visual Health

The Effectiveness of the Dot Card Therapy Towards Convergence Insufficiency Patients Among Young Adults

Background and Context

Convergence insufficiency (CI) is a common binocular vision disorder characterised by an inability to maintain proper alignment of the eyes when focusing on near objects. It has been reported that the frequency of this anomaly reaches as high as 6% among school children and young adults, making it one of the most prevalent binocular vision conditions encountered in clinical optometric practice. The condition can significantly affect quality of life and near work performance, causing symptoms such as eye strain, headaches, blurred vision, double vision, difficulty concentrating during reading, and loss of place while reading.

For university students, who spend extended periods engaged in near-vision tasks such as reading, writing, and computer use, convergence insufficiency can be particularly debilitating. The condition may be misattributed to poor concentration or lack of academic motivation, leading to delayed diagnosis and unnecessary academic difficulty.

Several treatment modalities exist for convergence insufficiency, including office-based vergence/accommodative therapy, home-based pencil push-ups, computer-based vergence exercises, and prism glasses. The Dot Card therapy is a home-based convergence exercise that uses a card with a series of dots at varying distances from the patient’s nose. Despite its widespread clinical use, published research on the effectiveness of Dot Card therapy specifically is limited, creating a gap in the evidence base that this study addresses.

Study Design and Methodology

A total of 33 university students with convergence insufficiency problems participated in this prospective intervention study. The participants had a mean age of 22.55 ± 1.66 years, and the sample was predominantly female (88%). The study was conducted at Universiti Kebangsaan Malaysia from September 2016 to June 2017, with informed consent obtained from all participants.

Convergence insufficiency was diagnosed using standardised clinical criteria. Symptoms were quantified using the Convergence Insufficiency Symptom Survey (CISS), a validated instrument that provides a numerical score reflecting the severity and frequency of CI-related symptoms. Binocular vision components measured included the Near Point of Convergence (NPC), fusional vergence (including Positive Fusional Vergence or PFV at near), and phoria (assessed using the Maddox Wing for distance and near).

All measurements were taken before starting the Dot Card therapy and at follow-up visits at 2 weeks and 4 weeks. The Dot Card therapy protocol required participants to perform the exercises at home daily, following standardised instructions provided by the research team.

Principal Findings

The results demonstrated statistically and clinically significant improvements across multiple outcome measures after 4 weeks of Dot Card therapy. The CISS score decreased from 22.30 at baseline to 15.30 at the 4-week visit (p < 0.001), indicating a substantial reduction in symptom burden. A CISS score below 16 is generally considered the threshold for symptom resolution, meaning that the average participant achieved a clinically meaningful improvement.

The Near Point of Convergence improved from 11.08 cm to 6.50 cm (p < 0.001). A NPC greater than 6 cm is one of the diagnostic criteria for convergence insufficiency, and the mean reduction to 6.50 cm indicates that most participants achieved or approached the normal convergence range. Positive Fusional Vergence at near also showed significant improvement, increasing from 13.82 prism dioptres to 18.36 prism dioptres (p = 0.035), reflecting enhanced ability to maintain binocular alignment during near fixation.

Near phoria showed improvement from 2.12 exophoria to 1.79 exophoria, though this change did not reach statistical significance (p = 0.369). The improvement in phoria, while modest, was in the expected direction and may reflect the relatively short treatment duration.

Implications for Clinical Practice

These findings provide evidence supporting Dot Card therapy as an effective, accessible, and affordable treatment option for convergence insufficiency in young adults. Unlike office-based vergence therapy, which requires regular clinic visits and supervision by a trained therapist, Dot Card exercises can be performed independently at home, making them particularly suitable for students and working adults with time constraints.

The significant improvements achieved within just 4 weeks suggest that Dot Card therapy can produce meaningful results in a relatively short timeframe, though optimal treatment duration may extend beyond this period for some patients. Optometrists and ophthalmologists should consider incorporating Dot Card therapy into their treatment protocols for young adults with mild to moderate convergence insufficiency.

Limitations

The study lacked a control group, which means improvements cannot be definitively attributed to the Dot Card therapy alone rather than natural resolution or placebo effects. The predominantly female sample (88%) limits generalisability to male populations. Compliance with home exercises was self-reported and could not be independently verified. The 4-week follow-up period, while sufficient to demonstrate initial effectiveness, does not address long-term outcomes or the durability of improvements after cessation of therapy.

Significance

This study provides valuable clinical evidence for the effectiveness of Dot Card therapy in a Malaysian university student population. Given the high prevalence of convergence insufficiency and the limited availability of specialised vision therapy services in many parts of Malaysia, home-based treatments such as Dot Card therapy offer an accessible and evidence-supported option for managing this common binocular vision disorder.

← Back to MJPHM Home